{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:49:20Z","timestamp":1760906960793,"version":"build-2065373602"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.hoc.2011.11.005","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T08:42:49Z","timestamp":1323852169000},"page":"31-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Management of Cervical Precancers: A Global Perspective"],"prefix":"10.1016","volume":"26","author":[{"given":"Daniel","family":"Echelman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2010","series-title":"GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]","author":"Ferlay","key":"10.1016\/j.hoc.2011.11.005_bib1"},{"year":"2011","series-title":"Institute for Health Metrics and Evaluation. The Challenge Ahead: Progress and setbacks in breast and cervical cancer","author":"Yin","key":"10.1016\/j.hoc.2011.11.005_bib2"},{"key":"10.1016\/j.hoc.2011.11.005_bib3","unstructured":"Howlader N, Noone AM, Krapcho M, et\u00a0al, editors. SEER cancer statistics review, 1975-2008, National Cancer Institute. Bethesda (MD). Available at: http:\/\/seer.cancer.gov\/csr\/1975_2008\/. Based on November 2010 SEER data submission, posted to the SEER web site, 2011. Accessed November 21, 2011."},{"issue":"Suppl 8","key":"10.1016\/j.hoc.2011.11.005_bib4","doi-asserted-by":"crossref","first-page":"viii24","DOI":"10.1093\/annonc\/mdl984","article-title":"Cancer initiatives in developing countries","volume":"17","author":"Mellstedt","year":"2006","journal-title":"Ann Oncol"},{"issue":"Suppl 8","key":"10.1016\/j.hoc.2011.11.005_bib5","doi-asserted-by":"crossref","first-page":"viii32","DOI":"10.1093\/annonc\/mdl985","article-title":"Cancer initiatives in Sudan","volume":"17","author":"Hamad","year":"2006","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2011.11.005_bib6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/cncr.20467","article-title":"Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000","volume":"101","author":"Singh","year":"2004","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.hoc.2011.11.005_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000141498","article-title":"Cervical cancer: screening and therapeutic perspectives","volume":"17","author":"Sankaranarayanan","year":"2008","journal-title":"Med Princ Pract"},{"issue":"1","key":"10.1016\/j.hoc.2011.11.005_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1363\/3600604","article-title":"Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000","volume":"36","author":"Weinstock","year":"2004","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.hoc.2011.11.005_bib9","unstructured":"WHO\/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human papillomavirus and related cancers in United States of America. Summary Report 2010. Available at: www.who.int\/hpvcentre. Accessed November 6, 2011."},{"key":"10.1016\/j.hoc.2011.11.005_bib10","unstructured":"WHO\/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human papillomavirus and related cancers in world. Summary Report 2010. Available at: www.who.int\/hpvcentre. Accessed November 6, 2011."},{"issue":"8","key":"10.1016\/j.hoc.2011.11.005_bib11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.hoc.2011.11.005_bib12","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.hoc.2011.11.005_bib13","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Mu\u00f1oz","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.hoc.2011.11.005_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ogc.2008.09.006","article-title":"Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer","volume":"35","author":"Wheeler","year":"2008","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"2","key":"10.1016\/j.hoc.2011.11.005_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1479-828X.2010.01269.x","article-title":"HPV infection and cervical disease: a review","volume":"51","author":"Carter","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"12","key":"10.1016\/j.hoc.2011.11.005_bib16","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1158\/1055-9965.EPI-10-0645","article-title":"Behavioral\/lifestyle and immunologic factors associated with HPV infection among women older than 45 years","volume":"19","author":"Gonz\u00e1lez","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.hoc.2011.11.005_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.pop.2009.04.010","article-title":"Screening and prevention: cervical cancer","volume":"36","author":"Weinstein","year":"2009","journal-title":"Prim Care"},{"issue":"4","key":"10.1016\/j.hoc.2011.11.005_bib18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ogc.2007.09.004","article-title":"Cervical cancer prevention\u2014cervical screening: science in evolution","volume":"34","author":"Safaeian","year":"2007","journal-title":"Obstet Gynecol Clin North Am"},{"year":"2006","series-title":"Comprehensive cervical cancer control: a guide to essential practice","key":"10.1016\/j.hoc.2011.11.005_bib19"},{"key":"10.1016\/j.hoc.2011.11.005_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1309\/AJCPBRK7D1YIUWFP","article-title":"The reproducibility of CIN diagnoses among different pathologists: data from histology reviews from a multicenter randomized study","volume":"132","author":"Dalla Palma","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.hoc.2011.11.005_bib21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(08)70110-4","article-title":"Heterogeneity in CIN3 diagnosis","volume":"9","author":"Schiffman","year":"2008","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2011.11.005_bib22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review","volume":"12","author":"Ost\u00f6r","year":"1993","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2011.11.005_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.hoc.2011.11.005_bib24","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/j.1460-2075.1988.tb03013.x","article-title":"Comparison of the in\u00a0vitro transforming activities of human papillomavirus types","volume":"7","author":"Storey","year":"1988","journal-title":"EMBO J"},{"issue":"5","key":"10.1016\/j.hoc.2011.11.005_bib25","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.4049\/jimmunol.178.5.3186","article-title":"TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16","volume":"178","author":"Hasan","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.hoc.2011.11.005_bib26","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ygyno.2010.01.024","article-title":"Pathology and epidemiology of HPV infection in females","volume":"117","author":"Stanley","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2011.11.005_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.virol.2005.01.029","article-title":"HPV16, HPV18, and HIV infection may influence cervical cytokine intralesional levels","volume":"334","author":"Fernandes","year":"2005","journal-title":"Virology"},{"issue":"7609","key":"10.1016\/j.hoc.2011.11.005_bib28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.39196.740995.BE","article-title":"Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial","volume":"335","author":"Ronco","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.hoc.2011.11.005_bib29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-155-10-201111150-00376","article-title":"Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive services task force","volume":"155","author":"Whitlock","year":"2011","journal-title":"Ann Intern Med"},{"issue":"16","key":"10.1016\/j.hoc.2011.11.005_bib30","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2011.11.005_bib31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijgo.2009.10.005","article-title":"Cytology versus HPV testing for the detection of high-grade cervical lesions in women found positive on visual inspection in Mumbai, India","volume":"108","author":"Pimple","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"issue":"Suppl 2","key":"10.1016\/j.hoc.2011.11.005_bib32","first-page":"S4","article-title":"A\u00a0critical assessment of screening methods for cervical neoplasia","volume":"89","author":"Sankaranarayanan","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"issue":"23","key":"10.1016\/j.hoc.2011.11.005_bib33","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/jnci\/djp367","article-title":"Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting","volume":"101","author":"Leinonen","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.hoc.2011.11.005_bib34","doi-asserted-by":"crossref","first-page":"e24083","DOI":"10.1371\/journal.pone.0024083","article-title":"Triage of women with low-grade cervical lesions\u2014HPV mRNA testing versus repeat cytology","volume":"6","author":"S\u00f8rbye","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.hoc.2011.11.005_bib35","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European guidelines for quality assurance in cervical cancer screening. Second edition\u2014summary document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2011.11.005_bib36","unstructured":"Available at: www.uspstf.org. Accessed November 9, 2011."},{"key":"10.1016\/j.hoc.2011.11.005_bib37","unstructured":"Available at: www.asccp.org. Accessed November 9, 2011."},{"key":"10.1016\/j.hoc.2011.11.005_bib38","unstructured":"Available at: www.acs.org. Accessed November 9, 2011."},{"issue":"6","key":"10.1016\/j.hoc.2011.11.005_bib39","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/AOG.0b013e3181c6f8a4","article-title":"ACOG Practice Bulleting no. 109: Cervical cytology screening","volume":"114","author":"ACOG Committee on Practice Bulletins\u2014Gynecology","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"Suppl 3","key":"10.1016\/j.hoc.2011.11.005_bib40","article-title":"Chapter 8: screening for cervical cancer in developing countries","volume":"24","author":"Denny","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.hoc.2011.11.005_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(11)61522-5","article-title":"Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial","author":"Lazcano-Ponce","year":"2011","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.hoc.2011.11.005_bib42","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/jnci\/94.19.1469","article-title":"Costs and benefits of different strategies to screen for cervical cancer in less-developed countries","volume":"94","author":"Mandelblatt","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"year":"2002","series-title":"Cervical cancer screening in developing countries: report of a WHO Consultation","key":"10.1016\/j.hoc.2011.11.005_bib43"},{"issue":"Suppl 2","key":"10.1016\/j.hoc.2011.11.005_bib44","first-page":"S30","article-title":"Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy","volume":"89","author":"Blumenthal","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"issue":"9360","key":"10.1016\/j.hoc.2011.11.005_bib45","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0140-6736(03)12707-9","article-title":"Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project","volume":"361","author":"Gaffikin","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.hoc.2011.11.005_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.12.031","article-title":"Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana","volume":"196","author":"Blumenthal","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"17","key":"10.1016\/j.hoc.2011.11.005_bib47","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1001\/jama.294.17.2173","article-title":"Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial","volume":"294","author":"Denny","year":"2005","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.hoc.2011.11.005_bib48","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1001\/jama.285.24.3107","article-title":"Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness","volume":"285","author":"Goldie","year":"2001","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.hoc.2011.11.005_bib49","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMsa044278","article-title":"Cost-effectiveness of cervical-cancer screening in five developing countries","volume":"353","author":"Goldie","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2011.11.005_bib50","first-page":"421","article-title":"Assessing the acceptability of self-sampling for HPV among Haitian immigrant women: CBPR in action","volume":"21","author":"Barbee","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"4","key":"10.1016\/j.hoc.2011.11.005_bib51","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ijc.25731","article-title":"A\u00a0comparison of human papillomavirus testing of clinician-collected and self-collected samples during follow-up after screen-and-treat","volume":"129","author":"Taylor","year":"2011","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2011.11.005_bib52","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.canep.2009.10.013","article-title":"Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?","volume":"33","author":"Bhatla","year":"2009","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"10.1016\/j.hoc.2011.11.005_bib53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/LGT.0b013e3181cd6d36","article-title":"Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples","volume":"14","author":"Balasubramanian","year":"2010","journal-title":"J\u00a0Low Genit Tract Dis"},{"year":"2010","series-title":"Causes of death 2008 summary tables","author":"World Health Organization","key":"10.1016\/j.hoc.2011.11.005_bib54"},{"issue":"32","key":"10.1016\/j.hoc.2011.11.005_bib55","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1016\/j.vaccine.2008.04.053","article-title":"Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries","volume":"26","author":"Goldie","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.hoc.2011.11.005_bib56","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1371\/journal.pmed.0050132","article-title":"Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities","volume":"5","author":"Gakidou","year":"2008","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.hoc.2011.11.005_bib57","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/ijgc-00009577-200511000-00007","article-title":"An ethnographic study of cervical cancer among women in rural Kenya: is there a folk causal model?","volume":"15","author":"Gatune","year":"2005","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2011.11.005_bib58","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1471-0528.2009.02122.x","article-title":"Performance of colposcopy in five sub-Saharan African countries","volume":"116","author":"Muwonge","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.hoc.2011.11.005_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6920-6-13","article-title":"Knowledge, attitudes and practices on cervical cancer screening among the medical workers of Mulago Hospital, Uganda","volume":"6","author":"Mutyaba","year":"2006","journal-title":"BMC Med Educ"},{"issue":"1","key":"10.1016\/j.hoc.2011.11.005_bib60","first-page":"48","article-title":"Knowledge of cervical cancer and screening practices of nurses at a regional hospital in Tanzania","volume":"11","author":"Urasa","year":"2011","journal-title":"Afr Health Sci"},{"issue":"3","key":"10.1016\/j.hoc.2011.11.005_bib61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/pon.1144","article-title":"A\u00a0study of patients who appear with far advanced cancer at Yaounde General Hospital, Cameroon, Africa","volume":"16","author":"Ekortarl","year":"2007","journal-title":"Psychooncology"},{"issue":"2","key":"10.1016\/j.hoc.2011.11.005_bib62","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/01443610601124398","article-title":"Cervical cancer screening practices among general practitioners in Lagos Nigeria","volume":"27","author":"Anorlu","year":"2007","journal-title":"J\u00a0Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.hoc.2011.11.005_bib63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/LGT.0b013e3181c08f5e","article-title":"Knowledge and attitudes of adult Peruvian women vis-\u00e0-vis human papillomavirus (HPV), cervical cancer, and the HPV vaccine","volume":"14","author":"Lee","year":"2010","journal-title":"J\u00a0Low Genit Tract Dis"},{"issue":"2","key":"10.1016\/j.hoc.2011.11.005_bib64","first-page":"41","article-title":"Knowledge and attitude of general outpatient attendants in Nigeria to cervical cancer","volume":"44","author":"Ajayi","year":"1998","journal-title":"Cent Afr J Med"},{"issue":"10","key":"10.1016\/j.hoc.2011.11.005_bib65","first-page":"954","article-title":"Effective screening programmes for cervical cancer in low- and middle-income developing countries","volume":"79","author":"Sankaranarayanan","year":"2001","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.hoc.2011.11.005_bib66","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF03404903","article-title":"\u2018Before you teach me, I cannot know\u2019: immigrant women\u2019s barriers and enablers with regard to cervical cancer screening among different ethnolinguistic groups in Canada","volume":"102","author":"Redwood-Campbell","year":"2011","journal-title":"Can J Public Health"},{"issue":"6","key":"10.1016\/j.hoc.2011.11.005_bib67","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/13557850903248621","article-title":"HPV knowledge, attitudes, and cultural beliefs among Hispanic men and women living on the Texas-Mexico border","volume":"14","author":"Fernandez","year":"2009","journal-title":"Ethn Health"},{"issue":"7","key":"10.1016\/j.hoc.2011.11.005_bib68","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/annonc\/mdm105","article-title":"Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia","volume":"18","author":"Devi","year":"2007","journal-title":"Ann Oncol"},{"issue":"19","key":"10.1016\/j.hoc.2011.11.005_bib69","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"9686","key":"10.1016\/j.hoc.2011.11.005_bib70","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.hoc.2011.11.005_bib71","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"FUTURE II Study Group","year":"2007","journal-title":"N\u00a0Engl J Med"},{"volume":"volume 10","article-title":"Cervix cancer screening","year":"2005","key":"10.1016\/j.hoc.2011.11.005_bib72"},{"issue":"33","key":"10.1016\/j.hoc.2011.11.005_bib73","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1016\/j.vaccine.2007.05.058","article-title":"Cost-effectiveness of HPV 16, 18 vaccination in Brazil","volume":"25","author":"Goldie","year":"2007","journal-title":"Vaccine"},{"year":"2006","series-title":"Cervical cancer prevention in Peru: lessons learned from the TATI demonstration project","author":"Luciani","key":"10.1016\/j.hoc.2011.11.005_bib74"},{"key":"10.1016\/j.hoc.2011.11.005_bib75","unstructured":"National Guideline for Cervical Cancer Screening Programme. Department of Health, South Africa. Available at: www.kznhealth.gov.za\/cervicalcancer.pdf. Accessed November 21, 2011."},{"key":"10.1016\/j.hoc.2011.11.005_bib76","unstructured":"Guidelines for Cervical Cancer Screening Programme. National Cancer Control Program; 2006. Available at: www.cytoindia.com\/cytology%20eqa\/CCSP%20Guidelines.pdf. Accessed November 6, 2011."}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858811001626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858811001626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:57:14Z","timestamp":1760183834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858811001626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0889858811001626"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2011.11.005","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Cervical Precancers: A Global Perspective","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2011.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}